Finance

Beta
Lists
TCRT:NASDAQ
Alaunos Therapeutics Inc
$2.92
-4.58%
(-0.14) 1D
May 29, 1:35:42 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TCRT...
Open
$2.98
High
$3.02
Low
$2.87
Mkt. cap
7.13M
Avg. vol.
14.61K
Volume
15.52K
52-wk high
$6.20
52-wk low
$1.67
EPS
-$2.06
Beta
-1.13
Shares outstanding
2.42M
No. of employees
1
Open
$2.98
High
$3.02
Low
$2.87
Mkt. cap
7.13M
Avg. vol.
14.61K
Volume
15.52K
52-wk high
$6.20
52-wk low
$1.67
EPS
-$2.06
Beta
-1.13
Shares outstanding
2.42M
No. of employees
1
News stories
From sources across the web
About Alaunos Therapeutics Inc
CEO-
Employees1
Founded1998
Headquarters-
SectorBiotechnology
Websitealaunos.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
3.00K
-
Cost of goods sold
185.00K
469.00K
361.00K
427.00K
Cost of revenue
185.00K
469.00K
361.00K
427.00K
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
854.00K
718.00K
549.00K
585.00K
Operating expense
854.00K
718.00K
549.00K
585.00K
Total operating expenses
1.04M
1.19M
910.00K
1.01M
Operating income
-1.04M
-1.19M
-907.00K
-1.01M
Other non operating income
-12.00K
28.00K
14.00K
6.00K
EBT including unusual items
-1.05M
-1.16M
-893.00K
-1.01M
EBT excluding unusual items
-1.05M
-1.16M
-893.00K
-1.01M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.05M
-1.16M
-893.00K
-1.01M
Net profit margin
-
-
-29,766.67%
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.04M
-1.19M
-905.25K
-1.00M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer